Answers are grounded in this paper and cite their sources.
Female Hodgkin lymphoma (HL) survivors treated with chest radiotherapy (RT) at a young age have a strongly increased risk of breast cancer (BC). Studies in childhood cancer survivors have shown that doxorubicin exposure may also increase BC risk. Although doxorubicin is the cornerstone of HL chemotherapy, the association between doxorubicin and BC risk has not been examined in HL survivors treated at adult ages.
No takes yet. Share an insight, caveat, or question.
Neppelenbroek et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: